Organon & Co News

Organon & Co Spearheads Kahn Brothers' Strategic Portfolio Enhancements in Q1 2024

Yahoo FinanceMay 16 04:01

Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high

BenzingaMay 10 20:01

Organon Reports Pricing of $1 Billion Senior Notes Offering

Organon (OGN) said late Tuesday that it and its unit Organon Foreign Debt Co-Issuer have priced an offering of $500 million of 6.750% senior secured notes that mature in 2034. Organon said the issuers

MT NewswiresMay 8 19:37

Organon Announces Pricing of $1 Billion Senior Notes Offering

Seeking AlphaMay 8 16:06

Reported Earlier, Organon Prices $1B Dual Series Senior Notes: $500M 6.750% Secured, $500M 7.875% Unsecured, Both Due 2034

The Companies intend to use the net proceeds from the sale of the Notes to repay a portion of their borrowings under the Credit Facilities' U.S. dollar-denominated "tranche B" term loan and to pay the

BenzingaMay 8 16:02

Organon Announces Pricing of $1.0 Billion Senior Notes Offering

Organon (NYSE:OGN) ("Organon"), a global healthcare company with a focus on women's health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as

BusinesswireMay 8 08:20

Organon Announces Proposed $1.0B Senior Notes Offering

Organon (NYSE:OGN) ("Organon"), a global healthcare company with a focus on women's health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary

BenzingaMay 7 19:59

Organon & Co. (NYSE:OGN) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

It's been a good week for Organon & Co. (NYSE:OGN) shareholders, because the company has just released its latest quarterly results, and the shares gained 5.7% to US$19.61. It was a workmanlike

Simply Wall StMay 5 21:17

Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Yahoo FinanceMay 5 20:44

Organon First Quarter 2024 Earnings: EPS: US$0.79 (Vs US$0.70 in 1Q 2023)

Yahoo FinanceMay 4 20:43

Organon & Is Maintained at Neutral by Goldman Sachs

Organon & Is Maintained at Neutral by Goldman Sachs

Dow JonesMay 4 00:10

Goldman Sachs Maintains Neutral on Organon, Raises Price Target to $20

Goldman Sachs analyst Chris Shibutani maintains Organon (NYSE:OGN) with a Neutral and raises the price target from $18 to $20.

BenzingaMay 3 23:59

Organon & Co (OGN) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic ...

Yahoo FinanceMay 3 15:23

Organon & Co To Go Ex-Dividend On May 10th, 2024 With 0.28 USD Dividend Per Share

May 3rd - $Organon & Co(OGN.US)$ is trading ex-dividend on May 10th, 2024. Shareholders of record on May 13th, 2024 will receive 0.28 USD dividend per share on June 13th, 2024. The ex-dividend dat

Futu NewsMay 3 07:40

Organon Beats On Q1, Women's Health Leads the Charge

Organon & Co (NYSE:OGN) reported a 5% Y/Y increase in the first quarter of 2024 revenue, reaching around $1.622 billion, beating the consensus of $1.563 billion.Women's Health revenue increased by 11%

BenzingaMay 3 01:58

Research Alert: CFRA Retains Hold Opinion On Shares Of Organon & Co.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target price to $1

MT NewswiresMay 3 00:35

Earnings Call Summary | Organon & Co(OGN.US) Q1 2024 Earnings Conference

The following is a summary of the Organon & Co. (OGN) Q1 2024 Earnings Call Transcript:Financial Performance:Organon reported Q1 revenue of $1.6 billion, a 7% growth at constant currency.Adjusted EBIT

Futu NewsMay 3 00:02 · Conference Call

Organon's Q1 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance, Quarterly Dividend Maintained

Organon (OGN) reported Q1 adjusted earnings Thursday of $1.22 per diluted share, up from $1.08 a year earlier. Analysts polled by Capital IQ expected $0.93. Revenue for the quarter ended March 31 was

MT NewswiresMay 2 22:56

Organon & Co (OGN) Q1 2024 Earnings: Exceeds Revenue Expectations, Aligns With EPS Projections

Yahoo FinanceMay 2 21:13

Organon Reaffirms 2024 Revenues Guidance Of $6.2B-$6.5B Versus Consensus Of $6.37B

Organon Reaffirms 2024 Revenues Guidance Of $6.2B-$6.5B Versus Consensus Of $6.37B

BenzingaMay 2 19:34